S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Vir Biotechnology (VIR) SEC Filings & 10K Form

$7.96
-0.29 (-3.52%)
(As of 04/18/2024 ET)

Recent Vir Biotechnology SEC Filings

DateFilerForm TypeView
04/04/2024
3:14 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:58 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:18 AM
Lee Sung (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:32 PM
Lee Sung (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:32 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:34 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:30 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:31 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:32 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
8:02 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:35 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:56 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
6:59 AM
STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
Form SC 13G
01/23/2024
3:14 PM
BlackRock Inc. (Filed by)
Vir Biotechnology (Subject)
Form SC 13G/A
01/03/2024
1:47 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
3:33 PM
Vir Biotechnology (Filer)
Form S-3ASR
11/03/2023
3:37 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
1:15 PM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
1:14 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
7:01 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
5:02 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
2:54 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:14 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
7:04 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:15 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
4:17 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
4:01 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/22/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
3:30 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
4:58 PM
Horn Howard (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2023
11:19 AM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
11:20 AM
Rice Steven J. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
3:25 PM
Ramasastry Saira (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2023
3:27 PM
Rice Steven J. (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/25/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
3:16 PM
NELSEN ROBERT (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
You’re invited: Biggest crypto event of 2024 (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.
05/24/2023
1:34 PM
Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:35 PM
SHARP PHILLIP A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:37 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:41 PM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:42 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:44 PM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:44 PM
PEREZ ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:33 PM
Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
3:06 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VIR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners